Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency.

Gibson KM, Jakobs C, Ogier H, Hagenfeldt L, Eeg-Olofsson KE, Eeg-Olofsson O, Aksu F, Weber HP, Rossier E, Vollmer B, et al.

J Inherit Metab Dis. 1995;18(2):143-6. No abstract available.

PMID:
7564230
2.

4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism.

Gibson KM, Hoffmann GF, Hodson AK, Bottiglieri T, Jakobs C.

Neuropediatrics. 1998 Feb;29(1):14-22. Review.

PMID:
9553943
3.

Inherited disorders of GABA metabolism.

Jakobs C, Jaeken J, Gibson KM.

J Inherit Metab Dis. 1993;16(4):704-15. Review.

PMID:
8412016
4.

Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.

Gropman A.

Ann Neurol. 2003;54 Suppl 6:S66-72. Review.

PMID:
12891656
5.

GABA, gamma-hydroxybutyric acid, and neurological disease.

Wong CG, Bottiglieri T, Snead OC 3rd.

Ann Neurol. 2003;54 Suppl 6:S3-12. Review.

PMID:
12891648
6.

[4-Hydroxybutyric aciduria].

Asai M, Wada Y.

Ryoikibetsu Shokogun Shirizu. 1998;(18 Pt 1):250-1. Review. Japanese. No abstract available.

PMID:
9590039
7.
8.

Clinical aspects of the disorders of GABA metabolism in children.

Pearl PL, Gibson KM.

Curr Opin Neurol. 2004 Apr;17(2):107-13. Review.

PMID:
15021235
9.

Central actions of valproic acid in man and in experimental models of epilepsy.

Hammond EJ, Wilder BJ, Bruni J.

Life Sci. 1981 Dec 21;29(25):2561-74. Review. No abstract available.

PMID:
6275228
10.

[Acute psychosis and vigabatrin in childhood].

Chiaretti A, Castorina M, Tortorolo L, Piastra M, Polidori G.

Pediatr Med Chir. 1994 Sep-Oct;16(5):489-90. Review. Italian.

PMID:
7885961
11.

A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.

Srinivasan J, Richens A.

Drug Saf. 1994 May;10(5):395-405. Review.

PMID:
8037889
12.

Succinic semialdehyde dehydrogenase deficiency in children and adults.

Pearl PL, Novotny EJ, Acosta MT, Jakobs C, Gibson KM.

Ann Neurol. 2003;54 Suppl 6:S73-80. Review.

PMID:
12891657
13.

Murine succinate semialdehyde dehydrogenase deficiency.

Gupta M, Hogema BM, Grompe M, Bottiglieri TG, Concas A, Biggio G, Sogliano C, Rigamonti AE, Pearl PL, Snead OC 3rd, Jakobs C, Gibson KM.

Ann Neurol. 2003;54 Suppl 6:S81-90. Review.

PMID:
12891658
14.

[Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].

Vogt H, Krämer G.

Schweiz Med Wochenschr. 1995 Jan 28;125(4):125-32. Review. German.

PMID:
7878401
15.

Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.

Mattson RH, Petroff O, Rothman D, Behar K.

Epilepsia. 1994;35 Suppl 5:S29-32. Review.

PMID:
8039467
16.

[The neurotransmitter inhibitor GABA, the basis of the mechanism of action of several drugs affecting the central nervous system].

Rodríguez-Trelles FA.

An R Acad Nac Med (Madr). 1984;101(4):431-52. Review. Spanish. No abstract available.

PMID:
6152518
17.

Review: Normal and abnormal central nervous system GABA metabolism in childhood.

Jaeken J, Casaer P, Haegele KD, Schechter PJ.

J Inherit Metab Dis. 1990;13(6):793-801. Review.

PMID:
2079831
18.

Supplemental Content

Support Center